An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease

被引：0
|
作者：
Shua-Haim, JR [1 ]
Pass, MD [1 ]
Patel, S [1 ]
Lee, P [1 ]
Patel, P [1 ]
机构：
[1] Jersey Shore Univ Med Ctr, Neptune, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80659-6
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis
    Hansen, Richard A.
    Gartlehner, Gerald
    Webb, Aaron P.
    Morgan, Laura C.
    Moore, Charity G.
    Jonas, Daniel E.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2008, 3 (02) : 211 - 225
  • [22] Efficacy and safety of rivastigmine in patients with Alzheimer's disease:: international randomised controlled trial
    Rösler, M
    Anand, R
    Cicin-Sain, A
    Gauthier, S
    Agid, Y
    Dal-Bianco, P
    Stähelin, HB
    Hartman, R
    Gharabawi, M
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7184): : 633 - 638
  • [23] High dose rivastigmine (Exelon) for an Alzheimer's disease patient: A case report
    Shua-Haim, JR
    Pass, M
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 312 - 313
  • [24] Real-world Evaluation of Tolerability, Safety and Efficacy of Rivastigmine Oral Solution in Patients with Mild to Moderate Alzheimer's Disease Dementia
    Hsieh, Sun-Wung
    Chen, Jui-Cheng
    Chen, Nai-Ching
    Jhang, Kai-Ming
    Wang, Wenfu
    Yang, Yuan-Han
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2021, 19 (03) : 447 - 457
  • [25] Efficacy and safety of Rivastigmine (Exelon) in Alzheimer's disease patients with vascular risk factors
    Kumar, V
    Sugaya, K
    Messina, J
    Veach, J
    [J]. NEUROLOGY, 1999, 52 (06) : A395 - A396
  • [26] Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type
    Agid, Y
    Dubois, B
    Anand, R
    Gharabawi, G
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (12): : 837 - 845
  • [27] Rivastigmine in the treatment of Alzheimer's disease: an update
    Onor, Maria Luisa
    Trevisiol, Marianna
    Aguglia, Eugenio
    [J]. CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01): : 17 - 32
  • [28] The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease
    Farlow, Martin R.
    Grossberg, George
    Gauthier, Serge
    Meng, Xiangyi
    Olin, Jason T.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2441 - 2447
  • [29] Safety and tolerability of high dose donepezil in patients with Alzheimer's disease: A preliminary report of a pilot study
    Shua-Haim, JR
    Pass, M
    Patel, S
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 357
  • [30] An open randomized comparative study of clinical efficacy and safety of huperzine A and rivastigmine in treatment of Alzheimer disease
    Wu, Yuncheng
    Zhao, Yongbo
    Xie, Yaying
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S8 - S9
12345